I
Intelligent Bio Solutions Inc. (INBS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
$1.52
-0.24 (-13.64%)
Market Cap: $5.84M
Last updated: Nov 17, 2026 at 11:03 AM ET
Intelligent Bio Solutions Inc. (INBS) Valuation Multiples
Intelligent Bio Solutions (INBS) trades at 1.0x sales and 0.6x book value. Its P/B of 0.6x is below its 5-year median of 0.7x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 1.0x |
| Price to book | 0.6x |
| EV/FCF | 0.1x |
| PEG | N/A |
| FCF yield | -253.2% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 0.6x | 0.7x | N/A |
Valuation History
Over the 5 of the 6 year ends shown that have a P/B, its P/B ranged from 0.4x in 2022 to 8.7x in 2024.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $9.53 | N/A | 0.8x |
| 2024 | $14.00 | 0.7x | 8.7x |
| 2023 | $40.56 | 0.3x | 1.2x |
| 2022 | $479.95 | N/A | 0.4x |
| 2021 | $3,445.38 | N/A | 2.1x |
| 2020 | $17,767.11 | N/A | N/A |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INBS
Is INBS stock overvalued?
GNG's valuation label for INBS is Undervalued.
What is INBS's price to sales ratio?
Intelligent Bio Solutions has a price to sales ratio of 1.0x.
INBS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors